Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

37.5%

3 terminated/withdrawn out of 8 trials

Success Rate

62.5%

-24.0% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04942938Not ApplicableCompleted

Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MS

Role: lead

NCT04909463Not ApplicableTerminated

Effects of Using the Duracore Splinting Device on Patient Outcomes Related to Chest Trauma

Role: lead

NCT05491382Not ApplicableWithdrawn

Muscle and Body Temperature Responses During Uphill and Downhill Running

Role: lead

NCT04186598Not ApplicableCompleted

Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema

Role: lead

NCT03928015Phase 2Withdrawn

Evaluation of Dronabinol For Acute Pain Following Traumatic Injury

Role: lead

NCT02693457Not ApplicableCompleted

Outcomes Following Suction Drain and Non-suction Drain Assisted Total Knee Arthroplasty

Role: collaborator

NCT02203045Not ApplicableCompleted

Outcomes Following Tourniquet and Non-Tourniquet Assisted Total Knee Arthroplasty

Role: collaborator

NCT02023281Not ApplicableCompleted

The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers

Role: collaborator

All 8 trials loaded